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Abstract
Cytokines contribute to pancreatic b-cell apoptosis in type 1 diabetes (T1D) by modulation of b-cell gene expression
networks. The transcription factor Activator Protein-1 (AP-1) is a key regulator of inflammation and apoptosis. We presently
evaluated the function of the AP-1 subunit JunB in cytokine-mediated b-cell dysfunction and death. The cytokines IL-
1b+IFN-c induced an early and transitory upregulation of JunB by NF-kB activation. Knockdown of JunB by RNA interference
increased cytokine-mediated expression of inducible nitric oxide synthase (iNOS) and endoplasmic reticulum (ER) stress
markers, leading to increased apoptosis in an insulin-producing cell line (INS-1E) and in purified rat primary b-cells. JunB
knockdown b-cells and junB
2/2 fibroblasts were also more sensitive to the chemical ER stressor cyclopiazonic acid (CPA).
Conversely, adenoviral-mediated overexpression of JunB diminished iNOS and ER markers expression and protected b-cells
from cytokine-induced cell death. These findings demonstrate a novel and unexpected role for JunB as a regulator of
defense mechanisms against cytokine- and ER stress-mediated apoptosis.
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Introduction
Diabetes mellitus is characterized by high levels of blood glucose
resulting from defects in insulin production, insulin action or both.
The two main forms of diabetes are type 1 (T1D) and type 2
diabetes (T2D). Both types are characterized by progressive
pancreatic b-cell loss, which is more marked in T1D [1]. b-cell
death in T1D is mediated by a protracted autoimmune attack
where apoptosis is triggered by cytokines and by other mechanisms
such as Fas-FasL or granzyme B [2,3]. Previous microarray studies
from our group indicate that b-cells up- and down-regulate
complex gene networks in response to cytokines [4,5]. This altered
gene expression profile is regulated by key transcription factors
such as NF-kB and STAT-1 [1,5] and is responsible for activation
of pro-apoptotic execution pathways like endoplasmic reticulum
(ER) stress, resulting in b-cell dysfunction and death [6]. Of note,
b-cells seem to have insufficient defense responses against some of
these pro-inflammatory and pro-apoptosis pathways [7–9]. As a
whole, these observations indicate that signaling events occurring
inside the b-cells are decisive for their survival or death in diabetes.
The Activator Protein-1 (AP-1) transcription factor is a key
player in response to extracellular signals, including cytokines [10].
AP-1 is composed of a variety of dimers of JUN, FOS, ATF and
MAF families. These components share biochemical properties
but differ in their biological functions. AP-1 can induce cell
survival or death under stress conditions, and it is the balance
between the regulation of pro- and anti-apoptotic target genes
which determines the cell outcome. This balance varies from cell
to cell, and depends on both the activated AP-1 member(s) and on
the parallel regulation of other transcription factors [11]. Previous
studies from our group indicate that the AP-1 subcomponent JunB
is preferentially activated in human and rodent b-cells after
cytokine exposure [4,12,13], but the role of this protein remains
unclear. Here we investigated the effects of reducing or increasing
JunB levels in insulin-producing INS-1E cells and in FACS-
purified rat primary b-cells. We demonstrate that JunB counter-
acts cytokine-induced ER stress and apoptosis and might therefore
be part of defense mechanisms triggered by b-cells during
exposure to pro-inflammatory cytokines. Modulating JunB could
represent a novel strategy to ameliorate b-cell resistance to
immune damage.
Methods
Cell culture, treatments and nitric oxide (NO)
measurement
Pancreatic islets were isolated from adult Wistar rats (Charles
River Laboratories Belgium, Brussels, Belgium), housed and used
according to the guidelines of the Belgian Regulations for Animal
Care; the Ethical Committee for Animal Experiments of the ULB
approved the experimental protocols. Islets were isolated by
collagenase digestion, b-cells were purified by autofluorescence-
activated cell sorting (FACS, FACStar, Becton-Dickinson and Co.;
Sunnyvale, CA, USA) and pre-cultured for 48 h in HAM’s F-10
medium [14]. Insulin-producing INS-1E cells [15] were cultured
in RPMI-1640 medium (Invitrogen, Paisley, UK) supplemented
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2/2 and 3T3 wild-type mouse fibroblasts
[16] were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% FCS. Recombinant rat or
mouse IFN-c (100–500 U/ml, R&D Systems, Abingdon, UK) and
human recombinant IL-1b (10–50 U/ml, gift from Dr. C.W.
Reinolds, National Cancer Institute, Bethesda, MD, USA), and
mouse TNF-a (1000 U/ml, Innogenetics, Gent, Belgium) were
used. The NO blocker L-NMA (NG-methyl-L-arginine, Sigma,
Steinheim, Germany) was used at 2.5 M. Culture medium was
collected for nitrite determination (nitrite is a stable product of NO
oxidation) by the Griess method [4]. SP600125 and cyclopiazonic
acid (CPA) (Sigma) were dissolved in DMSO and used at a
concentration of 10 mM and 25 mM respectively. Cytokines, L-
NMA, and CPA concentrations were selected based on our
previous time course and dose-response studies [2,4,12].
Infection with recombinant adenoviruses
After 48 h pre-culture cells were infected either with AdLUC
(control luciferase expressing virus), AdIkB
(SA)2 (encoding a
previously described NF-kB super-repressor protein [17]) or
AdJunB (expressing the rat JunB protein, purchased from RIKEN
Bio Resource Center-Japan). Primary rat b-cells and INS-1E cells
were infected for 2 h at 37uC with a MOI of 10 for AdIkB
(SA)2 or
AdLUC in INS-1E cells, and with a MOI of 20 and 40 for AdJunB
and AdLUC in the INS-1E and primary b-cells, respectively.
Western blotting
Equal amounts of proteins were resolved by 10% SDS-PAGE.
Immunoblot analysis was performed with antibodies against JunB,
IkBa, inducible nitric oxide synthase (iNOS) and Chop (Santa
Cruz Biotechnology, CA, USA), p-Jun N-terminal Kinase (JNK)
and b-actin (Cell Signaling, Danvers, MA, USA) and a-tubulin
(Sigma). The proteins were detected using the corresponding
horseradish peroxidase-conjugated secondary antibody (Santa
Cruz Biotechnology), and chemiluminescence Supersignal (Pierce,
Rockford, IL, USA) quantified using Aida1D analysis software
(Fujifilm). Values of the protein of interest were corrected for b-
actin or a-tubulin. All Western blots shown in the figures are
representative of at least 2–3 experiments.
Cell death assay
The percentage of cell death was determined by two observers,
one of whom was unaware of sample identity, in $600 cells in
each experimental condition by inverted fluorescence microscopy
after addition of the DNA dyes Hoechst 33342 (20 mg/ml) and
propidium iodide (10 mg/ml) (HO/PI) [4]. This method is
quantitative and has been validated in pancreatic b-cells by
systematic comparisons with electron microscopy [18], determi-
nation of DNA strand breaks [19] and caspase-3 activation [5].
siRNA transfection
Cells were transfected overnight with 30 nM of siRNAs against
JunB or Chop (sequences are provided in Table S1) or medium
GC content inactive control siRNA (Invitrogen) using 1 mlo f
DharmaFECT
TM lipid reagent (Dharmacon, Chicago, IL, USA)
to 150 nM of siRNA in Opti-mem
R (Invitrogen). After overnight
incubation, transfection medium was replaced by regular culture
medium for cell recovery.
Real Time RT-PCR
mRNA expression was determined by real time RT-PCR using
SYBR Green fluorescence on a LightCycler instrument (Roche,
Manheim, Germany). Primer sequences for mouse and rat iNOS,
ATF4, BiP, XBP-1s and Chop are provided in Table S2.
Expression of the gene of interest was divided by the house
keeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and expressed as fold induction compared to control.
GAPDH expression is not modified under the present experimen-
tal conditions (data not shown).
Figure 1. Cytokine-induced JunB upregulation in INS-1E cells is
mediated via NF-kB activation. (A) INS-1E cells were treated with IL-
1b+IFN-c and JunB protein expression was determined by Western blot
at different time points. The two observed bands correspond to JunB
and its phosphorylated form. (B) JunB expression after cytokines and/or
L-NMA exposure. (C) INS-1E cells were infected with a recombinant
adenovirus expressing either luciferase (AdLUC) or the NF-kB nonde-
gradable inhibitor IkB
(SA)2 (AdIkB
(SA)2) and then exposed to IL-1b+IFN-c.
Expression of IkBa,I kBa
(SA)2 and JunB were determined by Western
blot. (D) INS-1E cells were treated with cytokines (IL-1b+IFN-c) and/or
the JNK inhibitor SP600125 at different time points as indicated, JunB
and p-JNK expression were measured by Western blot.
doi:10.1371/journal.pone.0003030.g001
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ChIP assays were performed as described [20]. Extracts were
precleared by 1 h incubation with protein A/Herring sperm
DNA, and IP was performed by incubating overnight at 4uC with
the JunB antibody (sc-73, Santa Cruz Biotechnology) or using
preimmune serum as negative control. Primer sequences for the
AP-1 sites within rat iNOS and Chop promoter are provided in
Table S3.
Statistical analysis
Data are shown as means6SEM, and comparisons between
groups were made by paired t test or by ANOVA followed by t test
with Bonferroni correction for multiple comparisons.
Results and Discussion
JunB protein expression and its phosphorylation were increased
in insulin producing INS-1E cells as early as 2 hours after cytokine
addition. This lasted for up to 12 h, returning to basal levels after
24 h (Fig. 1A). NO generated by the inducible form of iNOS is an
important mediator of cytokine-driven changes in b-cell gene
expression [4]. JunB induction was not affected by the NO blocker
L-NMA, indicating a direct cytokine effect independent of NO
generation (Fig. 1B). NF-kB regulates JunB expression in
fibroblasts and endothelial cells [21,22]. Infection of INS-1E cells
with the adenovirus AdIkB
(SA)2 expressing an IkB‘ ‘ s u p e r - r e p r e s s o r ’ ’
prevented cytokine-induced NF-kB nuclear translocation (Fig.
S1) and abolished JunB induction (Fig. 1C), indicating that
cytokine-mediated JunB activation in b-cells is regulated by NF-
kB. It has been shown that JNK regulates the turnover of JunB
through its accelerated degradation induced by JNK-mediated
phosphorylation of the E3 ligase Itch [23]. To examine whether
JNK affects JunB stability, we exposed INS-1E cells to cytokines
and/or the JNK inhibitor SP600125. We observed that
reducing cytokine-mediated JNK activation leads to increased
JunB protein expression (Fig. 1D), in agreement with data in
other cell types [23,24].
To study the role of JunB in cytokine-mediated effects, we used
RNAi technology to selectively knockdown JunB. Two different
JunB siRNAs inhibited JunB protein expression by .65% as
compared with an inactive control siRNA in INS-1E cells (Fig. 2A,
quantification in Fig. S2). JunB knockdown did not affect viability
under basal conditions, but it increased cytokine-induced apoptosis
by 2-fold at 24 h (Fig. 2B). The siRNA JunB-2, which induced a
more marked knockdown effect, increased cytokine-mediated b-
cell death to a larger extent. In line with these observations,
primary b-cells were also sensitized to cytokine-induced apoptosis
after JunB knockdown (Fig. 2C,D). Previous studies have shown
that a junB transgene prevents liver apoptosis in c-jun
2/2 embryos
[25], while JunB inactivation induces cell death in c-Jun knockout
fibroblasts [24]. To the best of our knowledge, there are no
previous reports demonstrating a role of this protein in cytokine-
mediated apoptosis.
Figure 2. JunB knockdown augments cytokine-induced b-cell death. (A) INS-1E cells were transfected with inactive (Control) or two different
active JunB siRNAs; Western blot for JunB was performed 8 h after cytokine exposure. Non-transfected cells (NT) were used as additional control.
(B) Cytokines were added for 8 or 24 h to INS-1E cells and cell death was measured by HO/PI. (C) Purified rat b-cells were transfected with control or
with JunB siRNAs, and Western blot for JunB was performed 8 h after cytokine addition. (D) JunB knockdown increases primary b-cell death 48 h
after cytokine treatment. Results are the means6SEM of 3-5 independent experiments. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0003030.g002
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production, which has been shown to contribute to b-cell death
[2]. JunB knockdown potentiated iNOS mRNA and protein
induction after cytokine treatment (Fig. 3A,B). Consistently, higher
levels of the NO product nitrite were detected in the culture
medium of cytokine-treated JunB knockdown cells (Fig. 3C). iNOS
production is primarily controlled at the transcriptional level [26]
and the iNOS promoter contains several binding sites for AP-1
[27,28]. ChIP analysis using a JunB antibody demonstrated JunB
binding to two of the five different putative AP-1 binding sites in
the iNOS promoter (Fig. 3D). These data indicate that JunB might
act as a direct transcriptional repressor of iNOS expression. To
determine whether the effects of JunB are specific for pancreatic b-
cells, we exposed wild-type or JunB knockout fibroblasts to
cytokines. The treatment markedly increased iNOS expression
and NO production leading to cell death in JunB knockout
fibroblasts, but not in wild-type cells (Fig. 3E–G). Furthermore, L-
NMA attenuated cytokine-induced apoptosis in junB
2/2 fibro-
Figure 3. JunB inactivation upregulates cytokine-induced iNOS expression. (A) INS-1E cells were transfected with control or JunB siRNAs
and treated with cytokines. iNOS expression was examined at different time points by real time RT-PCR. (B) Western blot demonstrating increased
expression of iNOS protein in the cytokine-treated JunB knockdown cells. (C) Nitrite accumulation in the culture medium. (D) Schematic
representation of the rat iNOS promoter with putative AP-1 binding sites and the localization of the primers used. ChIP reveals binding of JunB to the
iNOS promoter 4 h after cytokine treatment in two of the five putative AP-1 binding sites as assessed by PCR. (E) Wild-type or junB
2/2 fibroblasts
were treated with cytokines (IL-1b+IFN-c+TNF-a) for 24 h, JunB and iNOS expression were measured by Western blot. (F) Increased nitrite production
by JunB knockout fibroblasts. (G) Cell death in fibroblasts as measured by HO/PI. (H) Cytokine-induced cell death in junB
2/2 fibroblasts was partially
prevented by L-NMA. Results are the means6SEM of 3 independent experiments. *P,0.05.
doi:10.1371/journal.pone.0003030.g003
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this model and that JunB prevents cytokine-mediated iNOS
expression and NO toxicity in different cell types.
IL-1b+IFN-c decrease the expression of the sarco(endo)plasmic
reticulum calcium ATPase (SERCA2) in b-cells via NO synthesis,
thereby depleting ER Ca
2+ stores and causing ER stress [29]. The
transcription factor Chop is a key regulator of ER stress–mediated
apoptosis [6,30,31]. Cytokines induce Chop expression in b-cells,
and this was shown to be NO- and AP-1-dependent [12]. JunB
knockdown induced an early upregulation of Chop mRNA and
protein after cytokine addition (Fig. 4A,B). ChIP assay using
primers designed to amplify the unique AP-1 site in the regulatory
sequence of the chop gene [12] indicated strong JunB binding after
cytokine treatment (Fig. 4C). This confirms physical interaction of
JunB with the chop promoter, and suggests that JunB negatively
regulates Chop expression, in agreement with our previous
observation that mutation of the AP-1 site in the chop promoter
increases basal activity, presumably by dissociating an inhibitory
Figure 4. Chop expression is upregulated in JunB knockdown and cytokine-treated cells. (A) RT-PCR of INS-1E cells transfected with
control or JunB siRNAs and treated with cytokines. (B) Increased Chop protein expression after JunB knockdown and cytokine treatment was
confirmed by Western blot. (C) Ethidium bromide-stained agarose gel of PCR products obtained with primers flanking the AP-1 binding site in the
Chop promoter. After cytokine treatment, IP was done for JunB or control (2). (D) Chop mRNA expression is increased in JunB knockdown b-cells
15 h after the CPA (25 mM) addition. (E) Cell death in siRNA transfected INS-1E cells treated with CPA. (F) Fibroblasts were transfected with control or
Chop siRNAs and Western blot for Chop was performed 24 h after CPA addition. Non-transfected cells (NT) were used as an additional control.
(G) siRNA-mediated Chop knockdown decreased fibroblast cell death 24 h after CPA addition. Results are the means6SEM of 3 independent
experiments. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0003030.g004
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with JunB siRNAs or fibroblasts lacking JunB to the chemical ER
stressor CPA, a SERCA2 blocker that induces Chop and ER
stress-mediated cell death independently of NO [12]. Addition of
CPA increased Chop expression and apoptosis in JunB knock-
down b-cells (Fig. 4D,E). Interestingly, junB
2/2 fibroblasts were
also more sensitive to CPA-induced apoptosis and increased Chop
mRNA and protein expression compared to wild-type cells (Fig.
S3A–C). Chop expression was regulated at the promoter level as
indicated by experiments using a Chop promoter luciferase reporter
construct (Fig. S3D). These data indicate that JunB negatively
modulates ER stress-induced Chop expression independently of
NO induction, presumably via direct transcriptional repression.
Chop knockdown by siRNA prevented CPA-induced apoptosis in
junB
2/2 fibroblasts (Fig. 4F,G), indicating that Chop is a crucial
mediator of ER stress-induced apoptosis. Importantly, JunB
inactivation also increased expression of the ER stress markers
BiP, XBP-1s and ATF4 after cytokine (INS-1E cells) or CPA
treatment (INS-1E cells and fibroblasts) (Figs. 5 and 6) suggesting
that all major pathways of the ER stress response are negatively
regulated by JunB.
Since JunB knockdown or knockout aggravated ER stress and
apoptosis, we next examined whether overexpression of JunB
protects b-cells from cytokine-induced cell death. JunB was
overexpressed using an adenoviral vector containing the rat
JunB cDNA [32] under the control of the CAG promoter [33].
Figure 5. Real time RT-PCR for ER stress markers in INS-1E cells after cytokines addition at the indicated time points (A) or 15 h CPA
treatment (B). Results are the means6SEM of 3 independent experiments. *P,0.05.
doi:10.1371/journal.pone.0003030.g005
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at the different multiplicity of infections (MOIs) tested (Fig. 7A);
we selected MOI 20 for subsequent experiments. JunB
overexpression reduced cytokine-mediated iNOS and Chop
induction (Fig. 7B,C), and diminished nitrite production
(Fig. 7D). In addition, INS-1E cells infected with AdJunB and
exposed to cytokines or CPA displayed significantly decreased
BiP but not XBP-1s or ATF4 expression (Fig. S4). Most
importantly, prolonged JunB overexpression protected both
INS-1E and primary b-cells against cytokine-induced apoptosis
(Fig. 7E–G).
Taken together, our data show a cytokine-mediated early
upregulation of JunB in b-cells. JunB induction is controlled by
NF-kB, while its late return to base line is probably secondary to
cytokine-triggered JNK activation and subsequent JunB degrada-
tion. It is thus conceivable that the previously reported pro-
apoptotic role of JNK in cytokine-treated b-cells [34,35] is at least
partially mediated by JNK-induced JunB degradation (present
data). It is noteworthy that while adenoviral-sustained overexpres-
sion of JunB protects b-cells against cytokine-mediated apoptosis
(Fig. 7), endogenous cytokine-induced JunB expression fails to
prevent cell death. This is probably related to the transitory nature
of JunB expression, which peaks around 8 h and returns to baseline
by 24 h after cytokine addition (Fig. 1), the time point when a
significant increase in apoptosis is observed (Fig. 2B). Our results
are in line with previous reports indicating that b-cell sensitivity to
cytokine-induced cell death is aggravated by its feeble and/or
transitory induction of protective genes such as XIAP [36], Bcl-6
[7] or suppressor of cytokine signaling (SOCS)-3 [37]. We show
that JunB is a key regulator of the cytokine-induced ER stress
response in b-cells.There areconflicting data, however, on whether
cytokine-induced ER stress is relevant for b-cell apoptosis. Thus,
while some studies indicate that upregulation of the chaperone BiP
[38] or blocking Chop [6,31] prevents cytokine-induced b-cell
death, other studies failed to observe a protective effect of chemical
chaperones and siRNA targeting Chop [39] or described a
dissociation between IL-1 induced ER stress and caspase-3 activity
[40]. As described in Fig. 8, the protective mechanism of JunB in
cytokine-induced b-cell apoptosis is mediated, at least in part, via
inhibitionof iNOSand ER stressmarkers expression.However,it is
likely that JunB also regulates other pro- or anti-apoptotic pathways
that remain to be determined.
In conclusion, we demonstrate that JunB plays an unexpected
protective role against cytokine-induced apoptosis in pancreatic
b-cells. Knockdown of this AP-1 component aggravates
cytokine-mediated cell death, whereas JunB overexpression
protects b-cells from apoptosis. These findings suggest that
increasing JunB expression could improve b-cell survival in early
diabetes.
Supporting Information
Figure S1 Cells were plated in poly-lysine coated cover slips
and, after 30 min treatment with cytokines, fixed with 4%
paraformaldehyde and permeabilized with 70% acetone+30%
methanol. Cells were then incubated for 1 h with anti-p65
antibody (sc-372, Santa Cruz Biotechnology) at 1:500 dilution.
The secondary antibody FITC conjugated anti-rabbit IgG
(Jackson ImmunoResearch; diluted 1:200) was used for visualiza-
tion by inverted fluorescence microscopy (Zeiss Axiovert 200,
Oberkochen-Germany). NF-kB activation was evaluated by
presence of its p65 subunit in the nucleus. We have previously
shown that p65 is the main constituent of NF-kB in cytokine-
treated b-cells (Ortis F, Cardozo AK, Crispim D, Storling J,
Mandrup-Poulsen T, et al. (2006) Cytokine-Induced Proapoptotic
Gene Expression in Insulin-Producing Cells Is Related to Rapid,
Sustained, and Nonoscillatory Nuclear Factor-kB Activation. Mol
Endocrinol 20: 1867–1879).
Found at: doi:10.1371/journal.pone.0003030.s001 (0.34 MB JPG)
Figure S2 Densitometry quantification of three experiments
performed as shown in Figure 2A. *P,0.05, **P,0.01.
Found at: doi:10.1371/journal.pone.0003030.s002 (0.37 MB TIF)
Figure 6. Real time RT-PCR for ER stress markers in fibroblasts
24 h after cytokine or CPA treatment. Results are the means6SEM
of 3 independent experiments. *P,0.05.
doi:10.1371/journal.pone.0003030.g006
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KO fibroblasts. Wild-type or junB-/- fibroblasts were treated for
24 h with CPA (25 mM) and cell death was measured by HO/
PI. Increased Chop mRNA (B) and protein (C) expression in
JunB KO fibroblasts after CPA-induced ER stress was measured
by respectively RT-PCR and Western blot. (D) The hamster
Chop promoter (2782 to 21 bp) tethered to a luciferase
reporter gene was used [12]. Fibroblasts were transfected using
lipofectAMINE 2000 (Invitrogen) with 250 ng of the luciferase
reporter construct and 50 ng of the pRL-CMV plasmid (used as
internal control for transfection efficiency). Twenty-four hours
after transfection cells were exposed for 24 h to CPA. Luciferase
activities of cell lysates were determined and expressed as
Firefly/Renilla (relative luciferase activity). *P,0.05, **P,0.01,
***P,0.001.
Found at: doi:10.1371/journal.pone.0003030.s003 (0.48 MB
TIF)
Figure S4 Real time RT-PCR for ER stress markers in INS-1E
after AdLUC or AdJunB infection and subsequent 24 h cytokine
or CPA treatment. Results are the means6SEM of 3–6
independent experiments. *P,0.05, **P,0.01, ***P,0.001.
Found at: doi:10.1371/journal.pone.0003030.s004 (0.38 MB JPG)
Table S1 siRNA sequences for protein knockdown.
Found at: doi:10.1371/journal.pone.0003030.s005 (0.03 MB
DOC)
Figure 7. Adenovirus-mediated overexpression of JunB protects INS-1E and primary b-cells from apoptosis after cytokine
treatment. (A) Western blot showing JunB upregulation in INS-1E cells 24 h following infection with AdJunB at different MOIs. (B) iNOS and Chop
mRNA expression in adenovirus-infected and cytokine-treated INS-1E cells was analyzed by real time PCR. (C) Western blot showing upregulation of
JunB and downregulation of Chop and iNOS 24 h after infection of INS-1E cells with AdJunB compared with AdLUC (control) virus. (D) Nitrite
accumulation in the medium of cells used in A. (E) Adenovirus-infected cells were exposed to cytokines for 24 h and cell death was measured with
HO/PI. (F) Western blot showing JunB upregulation 48 h after infection of primary b-cells with AdJunB at different MOIs. (G) Percentage of cell death
(HO/PI) after cytokine treatment in primary b-cells infected with AdJunB or control AdLUC. Results are the means6SEM of 3 independent
experiments. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0003030.g007
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PLoS ONE | www.plosone.org 8 August 2008 | Volume 3 | Issue 8 | e3030Table S2 Primer sequences for real time RT-PCR.
Found at: doi:10.1371/journal.pone.0003030.s006 (0.03 MB
DOC)
Table S3 Primer sequences for analysis of JunB binding to the
rat iNOS and Chop promoters in the ChIP studies performed.
Found at: doi:10.1371/journal.pone.0003030.s007 (0.03 MB
DOC)
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